operative complications
Conditions
Interventions
Remazolam group:Sedation was induced by remimazolam
Control group:Sedation was induced by propofol
Sponsors
The First Affiliated Hospital, Medical School of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: This project will be applied to patients undergoing endoscopic cholangiopancreatography (ERCP). Inclusion criteria: 1. Age >18 years old; 2. Patients and their families signed the informed consent; 3. ASA grade I-III; 4. patients who understand and correctly use PCS equipment.
Exclusion criteria
Exclusion criteria: 1. Patients allergic to remimazolam tosilate used in PCS; 2. The patient had severe cardiopulmonary dysfunction and could not tolerate the physiological changes caused by sedative drugs; 3. Patients had severe coagulopathy or bleeding tendency, which may increase the risk during sedation; 4. patients with severe central nervous system history or sedative drug abuse history; 5. patients with difficult tracheal intubation, patients with severe sleep apnea syndrome or other sleep disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of patients who reached an appropriate state of sedation (Ramsay score 2-4) within 5 minutes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bispectral index;blood pressure;SPO2; | — |
Countries
China
Contacts
Public ContactZhu Yaomin
The First Affiliated Hospital, Medical School of Xi'an Jiaotong University
Outcome results
None listed